OR1A2 Activators
OR1A2 Activators are generally focused on the indirect modulation of the G-protein-coupled receptor (GPCR) signaling pathway. These activators predominantly influence adenylyl cyclase, phosphodiesterase (PDE), or protein kinase C (PKC), which play crucial roles in the GPCR signaling mechanism. By modifying the activity of these enzymes, these chemicals alter the concentrations of secondary messengers like cAMP, which in turn can affect the function and activation of GPCRs like OR1A2.
It's crucial to understand that the activation of OR1A2 by these chemicals is an indirect process, reliant on a broader signaling network. The chemicals listed serve as modulators of enzymes or secondary messengers that are key players in the GPCR pathways. Although these compounds do not directly bind to or activate OR1A2, they do enhance the intracellular conditions favorable for its activation. These compounds are predominantly inhibitors or activators of enzymes that manipulate the levels of cAMP, a critical secondary messenger in GPCR pathways, thereby establishing a cellular environment that facilitates the activation of OR1A2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that elevates intracellular cAMP levels, enhancing GPCR signaling, thereby indirectly activating OR1A2. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterase, increasing cAMP levels and indirectly augmenting GPCR signaling pathways that include OR1A2. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
cAMP analog that resists hydrolysis, prolonging activation of GPCRs, including OR1A2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator that can modulate downstream effects of GPCRs, indirectly activating OR1A2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
PP2A inhibitor that can enhance GPCR-mediated signaling and indirectly influence OR1A2. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective PDE4 inhibitor that elevates cAMP, thereby indirectly enhancing OR1A2 activity. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
PDE3 and PDE4 inhibitor that raises cAMP and cGMP levels, indirectly activating OR1A2. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Membrane-permeable cAMP analog that indirectly activates GPCRs like OR1A2. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
PDE3 inhibitor that increases cAMP levels, indirectly influencing OR1A2 activation. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
Another PKA inhibitor that in certain conditions may indirectly enhance OR1A2 activation through cAMP elevation. | ||||||